Objectives Tofacitinib is a Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA),
psoriatic arthritis (PsA) and ulcerative colitis, and has been investigated in psoriasis (PsO). …

… RITCHLIN,6 WENDI MALLEY,2 VIVIAN HERRERA,3 MELODY TRAN,7 … Ms Karki and Ms
Malley are full-time employees of Corrona. Drs. Palmer and Herrera are full-time employees of …

Psoriatic arthritis (PsA) is a chronic condition characterized by a diverse set of symptoms, from
swollen joints to nail disease to skin disease. A variety of treatment options are available, …

Objective. Psoriatic arthritis (PsA) is commonly comorbid with psoriasis; the extent of skin
lesions is a major contributor to psoriatic disease severity/burden. We evaluated whether extent …

This text provides a thorough resource on arterial blood gases, covering the full scope of
applications. This book is the first of its kind to focus on the needs of educators, students, and …

Background The monoclonal antibody guselkumab is the first selective inhibitor of the
interleukin-23 p19 subunit approved to treat adults with moderate-to-severe plaque psoriasis and …

Introduction Guselkumab is approved for the treatment of both moderate-to-severe plaque
psoriasis and active psoriatic arthritis (PsA) in the USA. However, little is known about patients …

Background Comorbid conditions are very common in rheumatoid arthritis (RA) and several
prior studies have clustered them using machine learning (ML). We applied various ML …

… Similar observations were made for PR, ER, TR, and RAR (136, 1 37; XH Leng, SY Tsai,
MJ Tsai, BW O'Malley, unpublished results). These results are consistent with results …

NUCLEAR receptor coregulators are coactivators or corepressors that are required by
nuclear receptors for efficient transcriptional regulation. In this context, we define coactivators, …